Boghaert; Erwin R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Boghaert; Erwin R..The latest application filed is for "anti-egfr antibody-drug conjugates".
- Boghaert; Erwin R. - Pleasant Prairie WI
- BOGHAERT; Erwin R. - Monroe NY
| Patent | Date |
|---|---|
| Anti-EGFR Antibody-Drug Conjugates App 20220226494 - Boghaert; Erwin R. ; et al. | 2022-07-21 |
| Therapeutic DLL4 Binding Proteins App 20200255508 - Kind Code | 2020-08-13 |
| Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors App 20200246323 - Kind Code | 2020-08-06 |
| BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20200246460 - Kind Code | 2020-08-06 |
| BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20200239553 - Ackler; Scott L. ; et al. | 2020-07-30 |
| Anti-egfr Antibody Drug Conjugates App 20190343961 - Boghaert; Erwin R. ; et al. | 2019-11-14 |
| Anti-egfr Antibody Drug Conjugates App 20190153108 - Boghaert; Erwin R. ; et al. | 2019-05-23 |
| Anti-egfr Antibody Drug Conjugates App 20190153107 - Boghaert; Erwin R. ; et al. | 2019-05-23 |
| BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20190142941 - Ackler; Scott L. ; et al. | 2019-05-16 |
| Therapeutic DLL4 Binding Proteins App 20180371071 - Benatuil; Lorenzo ; et al. | 2018-12-27 |
| Anti-5t4 Antibodies And Uses Thereof App 20180162937 - BOGHAERT; Erwin R. ; et al. | 2018-06-14 |
| Anti-5T4 antibodies and uses thereof Grant 9,902,771 - Boghaert , et al. February 27, 2 | 2018-02-27 |
| Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors App 20170182179 - Ackler; Scott L. ; et al. | 2017-06-29 |
| BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same App 20160339117 - Ackler; Scott L. ; et al. | 2016-11-24 |
| Therapeutic DLL4 binding proteins Grant 9,469,688 - Benatuil , et al. October 18, 2 | 2016-10-18 |
| Anti-5t4 Antibodies And Uses Thereof App 20160185859 - BOGHAERT; Erwin R. ; et al. | 2016-06-30 |
| BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same App 20160158377 - Ackler; Scott L. ; et al. | 2016-06-09 |
| Therapeutic Dll4 Binding Proteins App 20160060332 - Benatuil; Lorenzo ; et al. | 2016-03-03 |
| Therapeutic DLL4 binding proteins Grant 9,132,190 - Benatuil , et al. September 15, 2 | 2015-09-15 |
| Anti-5t4 Antibodies And Uses Thereof App 20140308302 - BOGHAERT; Erwin R. ; et al. | 2014-10-16 |
| Anti-5T4 antibodies and uses thereof Grant 8,759,495 - Boghaert , et al. June 24, 2 | 2014-06-24 |
| Therapeutic Dll4 Binding Proteins App 20140093521 - Benatuil; Lorenzo ; et al. | 2014-04-03 |
| Therapeutic DLL4 binding proteins Grant 8,623,358 - Benatuil , et al. January 7, 2 | 2014-01-07 |
| Anti-5t4 Antibodies And Uses Thereof App 20120064600 - BOGHAERT; Erwin R. ; et al. | 2012-03-15 |
| Anti-5T4 antibodies and uses thereof Grant 8,044,178 - Boghaert , et al. October 25, 2 | 2011-10-25 |
| Therapeutic Dll4 Binding Proteins App 20110117079 - Benatuil; Lorenzo ; et al. | 2011-05-19 |
| Humanized Anti-5t4 Antibodies And Anti-5t4/calicheamicin Conjugates App 20100173382 - Boghaert; Erwin R. ; et al. | 2010-07-08 |
| Humanized Anti-5t4 Antibodies And Anti-5t4/calicheamicin Conjugates App 20100021483 - BOGHAERT; ERWIN R. ; et al. | 2010-01-28 |
| Anti-5t4 Antibodies And Uses Thereof App 20070231333 - BOGHAERT; Erwin R. ; et al. | 2007-10-04 |
| Methods Of Determining Pharmacokinetics Of Targeted Therapies App 20070003559 - Khandke; Kiran ; et al. | 2007-01-04 |
| Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates App 20060088522 - Boghaert; Erwin R. ; et al. | 2006-04-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 